3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor (Biopharm technologies)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor (Biopharm technologies)
Drug Alias Namebrutieridinbrutieridin/melitidin (Biopharm technologies)bergamot juice flavonoids (Biopharm technologies)melitidin
ClassificationBiologics
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiopharm Technology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiopharm Technology Corp
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A